Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

High specific activity estradiol labeled with iodine-125 was used to detect approximately 200 saturable, high-affinity (dissociation constant approximately equal to 1.0 nM) nuclear binding sites in rat (ROS 17/2.8) and human (HOS TE85) clonal osteoblast-like osteosarcoma cells. Of the steroids tested, only testosterone exhibited significant cross-reactivity with estrogen binding. RNA blot analysis with a complementary DNA probe to the human estrogen receptor revealed putative receptor transcripts of 6 to 6.2 kilobases in both rat and human osteosarcoma cells. Type I procollagen and transforming growth factor-beta messenger RNA levels were enhanced in cultured human osteoblast-like cells treated with 1 nM estradiol. Thus, estrogen can act directly on osteoblasts by a receptor-mediated mechanism and thereby modulate the extracellular matrix and other proteins involved in the maintenance of skeletal mineralization and remodeling.

[1]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[2]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[3]  G. Mundy,et al.  Effects of Transforming Growth Factor-β on Osteoblastic Osteosarcoma Cells* , 1987 .

[4]  J. Massagué,et al.  Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[5]  B. Komm,et al.  Estrogen Regulation of α1(I)-Procollagen Messenger Ribonucleic Acid in the Rat Uterus* , 1987 .

[6]  S. Koike,et al.  Molecular cloning and characterization of rat estrogen receptor cDNA. , 1987, Nucleic acids research.

[7]  M. Haussler,et al.  Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. , 1987, Science.

[8]  R. Russell,et al.  1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. , 1986, Endocrinology.

[9]  P. Chambon,et al.  Cloning of the chicken progesterone receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[12]  C. Christiansen,et al.  UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS , 1985, The Lancet.

[13]  J. Vuust,et al.  Regulation of type I collagen synthesis. Total pro alpha 1(I) and pro alpha 2(I) mRNAs are maintained in a 2:1 ratio under varying rates of collagen synthesis. , 1985, European journal of biochemistry.

[14]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[15]  R. Evans,et al.  Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product , 1985, Nature.

[16]  B. O’Malley.  Steroid hormone action in eucaryotic cells. , 1984, The Journal of clinical investigation.

[17]  G. Greene,et al.  Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells , 1984, Nature.

[18]  R. Francis,et al.  The Effect of Estrogen Dose on Postmenopausal Bone Loss , 1983 .

[19]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[20]  J. Wergedal,et al.  Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro. , 1982, Biochemistry.

[21]  G. Sonenshein,et al.  Effects of 17 beta-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. , 1981, Biochemistry.

[22]  D. Baylink,et al.  Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency. , 1981, Metabolic bone disease & related research.

[23]  P. Thomas,et al.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[25]  W. Rosner,et al.  Interaction of 16 alpha-[125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Cruess,et al.  The effect of long term estrogen administration on bone metabolism in the female rat. , 1979, Endocrinology.

[27]  D. Feldman,et al.  Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone. , 1978, Endocrinology.

[28]  E. Jensen,et al.  Estrogen-Receptor Interaction , 1973, Science.

[29]  H. Soule,et al.  Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. , 1973, The Journal of biological chemistry.

[30]  P. Leder,et al.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Jensen,et al.  Mechanism of action of the female sex hormones. , 1972, Annual review of biochemistry.

[32]  Q. T. Smith,et al.  Changes of collagen content in skin, femur and uterus of 17-beta-estradiol benzoate-treated rats. , 1966, Endocrinology.